Principales collaborations

NATIONALES

- CNRS UMR 7312, Institut de Chimie Moléculaire, Reims.

- Laboratoire de Recherche en Nanosciences, EA 4682, Reims.

- Laboratoire de Physiologie Cellulaire et Moléculaire, EA 4667 - Université de Picardie-Jules-Verne, Amiens.

- CNRS UMR 5086, Institut de Biologie et de Chimie des Protéines (IBCP), Lyon.

- INSERM UMR 990, Université d’Auvergne, Clermont-Ferrand.

- Structure et Instabilité du Génome - Sorbonne Universités INSERM U1154 / CNRS UMR 7196 - Muséum National d'Histoire Naturelle, Paris

_____________________________________________________

INTERNATIONALES

- Department of Imaging and Pathology, KU Leuven, Belgium

- Center for Molecular Medecine, Department of Vascular Matrix Biology, University of Frankfurt, Germany.

- Departments of Medicine, Cell Biology and Ophthalmology, Johns Hopkins University, Baltimore, USA.

- Physiology & Experimental Medicine Program, Hospital for Sick Children, ON, Canada; Institute of Medical Science, University of Toronto, ON, Canada.

- Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.

- Proteome and Genome Research Unit and Laboratory of Experimental Cancer Research, CRP-Santé, Luxembourg.

- University of Monastir, Tunisia

____________________________________________________________________

Programme H2020 Marie SkÅ‚odowska-Curie Research and Innovation Staff Exchange (RISE) du consortium européen GLYCANC (Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer).

• EU consortium « GLYCANC », H2020-MSCA-RISE-2014, N°: SEP-210166639.
• Title: Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer.
Coordinator: Martin Götte, University de Münster, Germany. Duration: 4 years Partners: DE (2), FR (URCA), IT (2), EL (2), SE (1), HU (1), BR (1), EG (1), AR (1).